摘要
目的 比较艾司洛尔与胺碘酮在治疗重症患者快速心律失常的临床疗效。 方法 回顾性分析2018年6月至2019年6月在西部战区总医院重症医学科住院治疗期间发生快速性室上性心律失常患者186例的临床资料,根据治疗快速心律失常的药物,分为艾司洛尔组( n =130)与胺碘酮组( n =56),比较两组患者治疗前后的心率、血压变化情况以及药物治疗对血流动力学指标的影响。 结果 两组患者治疗后,艾司洛尔组患者更快达到目标心率;两组患者治疗前后血压及血流动力学指标变化情况无明显差异。 结论 治疗快速性室上性心律失常的重症患者时,艾司洛尔更快达到目标心率,且对血压和血流动力学状态影响不大。
Objective To compare the clinical effect between esmolol and amiodarone in treating severe cases with the treatment of supraventricular tachycardia(SVT).Methods The clinical data of 186 cases with SVT during the period from June,2018 to June,2019 were retrospectively analyzed;cases were divided into 2 groups:esmolol group(n=130)and amiodarone group(n=56);the variations in heart rate,blood pressure before and after treatment and the hemodynamic indices of cases after treatment were comparatively studied.Results Cases in esmolol group reached target heart rate faster than those in amiodarone group did;there were no significant differences in the blood pressure and hemodynamic indices of all cases between and after treatment.Conclusions Esmolol helps to reach the target heart rate in severe cases with SVT faster than amiodarone and it has liittle impact on cases’blood pressure and hemodynamic index.
作者
胡健
李运明
Hu Jian;Li Yunming(Department of Intensive Care Unit,Chengdu,Sichuan Province,610083,P.R.China;Department of Information,the General Hospital of Western Theater Command,Chengdu,Sichuan Province,610083,P.R.China)
出处
《西南军医》
2020年第1期1-3,共3页
Journal of Military Surgeon in Southwest China
基金
全军医学科技青年培育项目(项目编号:17QNP047)
